Gat Therapeutics
GAT Therapeutics is an early stage biopharma targeting orphan fibrotic diseases. We partner with leading researchers and clinicians to translate discoveries into patient outcomes. Our leading drug candidate GTX-011 has the potential to become mainstay therapy for orphan fibrotic diseases.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Gat Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- AM
Angel Manuel Valdivielso Pablo
Cmc Manager · General Business & Management
EmailPhone - CF
Consol Farrera
Senior Researcher · Research & Development
EmailPhone - CF
Cristina Fernández Asensio
Técnico De Laboratorio Bioquímico · Other
EmailPhone - SS
Silvia Sánchez Díez
Research & Development Scientist · Other
EmailPhone - ER
Eugènia Ruiz Cánovas
Chief Scientific Officer · Science
EmailPhone - LV
Lucía Vázquez Pagán
Preclinical Researcher in Drug Development for Pulmonary Fibrosis · Other
EmailPhone
Showing 6 of 6 verified contacts
Top roles at Gat Therapeutics
6 distinct titles indexed · top 6 shown.
- 1chief scientific officer
- 1cmc manager
- 1preclinical researcher in drug development for pulmonary fibrosis
- 1research & development scientist
- 1senior researcher
- 1técnico de laboratorio bioquímico
Sign up to unlock all 6 contacts at Gat Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Gat Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.